AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PREGABALIN 150.000 Mg ;

13 registrations across 1 African market— 13 active

Markets with PREGABALIN 150.000 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Pregaba 150mg
Hard Gelatin Capsules
🇪🇬EgyptEgyptian Group for Pharmaceutical Industries - EGPIactive
ANDOGABLIN 150mg
Hard Gelatin Capsules
🇪🇬Egyptal andalous for pharmaceutical industriesactive
HEXGABALIN 150mg
Hard Gelatin Capsules
🇪🇬EgyptGlobal NAPI Pharmaceuticals - GNPactive
SERIGABTIN 150mg
Hard Gelatin Capsules
🇪🇬EgyptSERIO PHARM-EGYPTactive
Dragonor 150 mg
Hard Gelatin Capsules
🇪🇬Egyptbioxell pharmaactive
Snapgab 150 mg
Hard Gelatin Capsules
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
SERIGABTIN 150mg
Hard Gelatin Capsules
🇪🇬EgyptSERIO PHARM-EGYPTactive
Snapgab 150 mg
Hard Gelatin Capsules
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
ANDOGABLIN 150mg
Hard Gelatin Capsules
🇪🇬Egyptal andalous for pharmaceutical industriesactive
HEXGABALIN 150mg
Hard Gelatin Capsules
🇪🇬EgyptGlobal NAPI Pharmaceuticals - GNPactive
Balinozar 150 mg
Hard Gelatin Capsules
🇪🇬Egyptpharma cure pharmaceutical industriesactive
MYAFIBROL 150 mg
Hard Gelatin Capsules
🇪🇬Egyptrotabiogen for Pharmaceutical Investments and Chemicalsactive
Pregaba 150mg
Hard Gelatin Capsules
🇪🇬EgyptEgyptian Group for Pharmaceutical Industries - EGPIactive

PREGABALIN 150.000 Mg ; in Africa — Regulatory Overview

PREGABALIN 150.000 Mg ; is registered across 1 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 13 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.